Evidence map›Paper›PMID 33407463›Full record

ArticleMalaria journal2021

Epidemiological profile of Plasmodium ovale spp. imported from Africa to Anhui Province, China, 2012-2019.

Tao Zhang, Shuqi Wang, Duoquan Wang, Sarah Auburn, Shenning Lu, Xian Xu, Jingjing Jiang, Xiaofeng Lyu, Chen Yu, Cuicui Tian and 2 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Tao ZhangAnhui Provincial Center for Disease Control and Prevention, Hefei, 230601, China.
Shuqi WangAnhui Provincial Center for Disease Control and Prevention, Hefei, 230601, China.
Duoquan WangNational Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai, 200025, China.
Sarah AuburnGlobal and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, NT, Australia.
Shenning LuNational Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai, 200025, China.
Xian XuAnhui Provincial Center for Disease Control and Prevention, Hefei, 230601, China.
Jingjing JiangAnhui Provincial Center for Disease Control and Prevention, Hefei, 230601, China.
Xiaofeng LyuAnhui Provincial Center for Disease Control and Prevention, Hefei, 230601, China.
Chen YuAnhui Provincial Center for Disease Control and Prevention, Hefei, 230601, China.
Cuicui TianAnhui Provincial Center for Disease Control and Prevention, Hefei, 230601, China.
Shizhu LiNational Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai, 200025, China. lisz@chinacdc.cn.
Weidong LiNational Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai, 200025, China. ahcdclwd@163.com.ORCID http://orcid.org/0000-0002-1486-0883
Anhui Provincial Center for Disease Control and Prevention · CNNational Institute for Parasitic Diseases · CNCharles Darwin University · AU

Funding

National Science and Technology Key Projects 2016ZX10004222-004
6 · The paper itself

Abstract

backgroundAlthough autochthonous malaria cases are no longer reported in Anhui Province, China, imported malaria has become a major health concern. The proportion of reported malaria cases caused by Plasmodium ovale spp. increased to levels higher than expected during 2012 to 2019, and showed two peaks, 19.69% in 2015 and 19.35% in 2018.

methodsA case-based retrospective study was performed using data collected from the China Information System for Disease Control and Prevention (CISDCP) and Information System for Parasitic Disease Control and Prevention (ISPDCP) from 2012 to 2019 to assess the trends and differences between Plasmodium ovale curtisi (P. o. curtisi) and Plasmodium ovale wallikeri (P. o. wallikeri). Epidemiological characteristics were analyzed using descriptive statistics.

resultsPlasmodium o. curtisi and P. o. wallikeri were found to simultaneously circulate in 14 African countries. Among 128 patients infected with P. ovale spp., the proportion of co-infection cases was 10.16%. Six cases of co-infection with P. ovale spp. and P. falciparum were noted, each presenting with two clinical attacks (the first attack was due to P. falciparum and the second was due to P. ovale spp.) at different intervals. Accurate identification of the infecting species was achieved among only 20.00% of cases of P. ovale spp. infection. At the reporting units, 32.17% and 6.96% of cases of P. ovale spp. infection were misdiagnosed as P. vivax and P. falciparum infections, respectively.

conclusionThe present results indicate that the potential of P. ovale spp. to co-infect with other Plasmodium species has been previously underestimated, as is the incidence of P. ovale spp. in countries where malaria is endemic. P. o. curtisi may have a long latency period of > 3 years and potentially cause residual foci, thus posing challenges to the elimination of malaria in P. ovale spp.-endemic areas. Considering the low rate of species identification, more sensitive point-of-care detection methods need to be developed for P. ovale spp. and introduced in non-endemic areas.

Indexed as

AfricaChinaCommunicable Diseases, ImportedIncidenceMalariaPlasmodium ovaleRetrospective StudiesAnhui provinceImported malariaPlasmodium ovale curtisiPlasmodium ovale spp.Plasmodium ovale wallikeri

Identifiers

PMID33407463
PMCPMC7788861
OpenAlexW3108730362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.